LOS ANGELES, April 09, 2019 (GLOBE NEWSWIRE) --
CURE Pharmaceutical
(CURR), an innovative drug delivery and
development company, today announced a global healthcare awareness
initiative with United Smart Cities for the purpose of educating,
informing and providing the next generation healthcare solutions to
the world’s 7.3 billion citizens.
Recognizing escalating healthcare costs, CURE and United Smart Cities will seek to promote education and innovation in delivering cost-effective and sustainable treatments to the world’s population.
“CURE was founded on the principles of affordability and global accessibility of medications,†said Rob Davidson, CEO of Cure Pharmaceutical. “We are driven to finding healthcare solutions for people of all ages and demographics and we are honored to be in service to this cause with United Smart Cities. Our mutual goal is to invigorate health and elevate living standards through education and sustainable new technologies.â€
“We are happy to add CURE Pharmaceutical into United Smart Cities’ private sector partnership pool,†said Kari Eik, United Smart Cities Co-Director, and Secretary General of OiER. “Health infrastructure is a key focus area for the United Smart Cities program, and we look forward to engaging with health solution providers from diverse sectors to jointly contribute to the development of robust, sustainable health infrastructure for smart sustainable cities worldwide.â€
About CURE
Pharmaceutical
CURE Pharmaceutical is a vertically integrated drug delivery and
development company committed to improving drug efficacy, safety
and the patient experience through its proprietary drug dosage
forms and delivery systems. CURE has a full-service cGMP
manufacturing facility and is a pioneering developer and
manufacturer of a patented and proprietary delivery system
(CUREfilmâ„¢), one of the most advanced oral thin film on the market
today. CURE is developing an array of products in cutting-edge
delivery platforms and partners with biotech and pharmaceutical
companies. CURE has positioned itself to advance numerous
therapeutic categories, including the pharmaceutical cannabis
sector with partnerships in the U.S., Canada, Israel and Germany,
among other markets. The company’s mission is to improve people’s
lives by redefining how medicines are delivered and
experienced.
For more information about CURE Pharmaceutical, please visit its
website at www.curepharma.com
About United Smart Cities
The United Smart Cities program is a global multi-stakeholder initiative, established by the Organization for International Economic Relations (OiER) in cooperation with the United Nations Economic Commission for Europe (UNECE) and other international organizations, cities, industry and finance sector. It is a unique platform that brings together international organizations, companies, governments and high-level decision makers to work together on one Goal: To support cities to become smarter and more sustainable and implement priority projects towards the achievement of the SDGs at the local level.
The aim of the United Smart Cities program is to evaluate cities’ performances and set priorities for action, develop analysis of cities (city profiles), support strategies in terms of urban planning and priorities (action plan), project development, finance options, and investors’ engagement in cooperation with urban experts and the private sector.
For more information about United Smart Cities, please visit www.unitedsmartcities.org
Media Inquiries:
Ashley Ray
310.824.9000
[email protected]